Cargando…
P18. The tumour leukocyte infiltrate is the key predictor for therapeutic response to catumaxomab therapy
| Autores principales: | , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
BioMed Central
2014
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4072014/ http://dx.doi.org/10.1186/2051-1426-2-S2-P9 |
| _version_ | 1782322889787179008 |
|---|---|
| author | Weiler, K Rava, L Jäger, M Funke, I Joka, M Jauch, KW Mayer, B |
| author_facet | Weiler, K Rava, L Jäger, M Funke, I Joka, M Jauch, KW Mayer, B |
| author_sort | Weiler, K |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-4072014 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2014 |
| publisher | BioMed Central |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-40720142014-06-27 P18. The tumour leukocyte infiltrate is the key predictor for therapeutic response to catumaxomab therapy Weiler, K Rava, L Jäger, M Funke, I Joka, M Jauch, KW Mayer, B J Immunother Cancer Poster Presentation BioMed Central 2014-03-12 /pmc/articles/PMC4072014/ http://dx.doi.org/10.1186/2051-1426-2-S2-P9 Text en Copyright © 2014 Weiler et al; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. |
| spellingShingle | Poster Presentation Weiler, K Rava, L Jäger, M Funke, I Joka, M Jauch, KW Mayer, B P18. The tumour leukocyte infiltrate is the key predictor for therapeutic response to catumaxomab therapy |
| title | P18. The tumour leukocyte infiltrate is the key predictor for therapeutic response to catumaxomab therapy |
| title_full | P18. The tumour leukocyte infiltrate is the key predictor for therapeutic response to catumaxomab therapy |
| title_fullStr | P18. The tumour leukocyte infiltrate is the key predictor for therapeutic response to catumaxomab therapy |
| title_full_unstemmed | P18. The tumour leukocyte infiltrate is the key predictor for therapeutic response to catumaxomab therapy |
| title_short | P18. The tumour leukocyte infiltrate is the key predictor for therapeutic response to catumaxomab therapy |
| title_sort | p18. the tumour leukocyte infiltrate is the key predictor for therapeutic response to catumaxomab therapy |
| topic | Poster Presentation |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4072014/ http://dx.doi.org/10.1186/2051-1426-2-S2-P9 |
| work_keys_str_mv | AT weilerk p18thetumourleukocyteinfiltrateisthekeypredictorfortherapeuticresponsetocatumaxomabtherapy AT raval p18thetumourleukocyteinfiltrateisthekeypredictorfortherapeuticresponsetocatumaxomabtherapy AT jagerm p18thetumourleukocyteinfiltrateisthekeypredictorfortherapeuticresponsetocatumaxomabtherapy AT funkei p18thetumourleukocyteinfiltrateisthekeypredictorfortherapeuticresponsetocatumaxomabtherapy AT jokam p18thetumourleukocyteinfiltrateisthekeypredictorfortherapeuticresponsetocatumaxomabtherapy AT jauchkw p18thetumourleukocyteinfiltrateisthekeypredictorfortherapeuticresponsetocatumaxomabtherapy AT mayerb p18thetumourleukocyteinfiltrateisthekeypredictorfortherapeuticresponsetocatumaxomabtherapy |